Cited by 184Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsEndometriosis Research and Treatment

Lifestyle Modification Programs in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis

Domecq, Juan Pablo, Prutsky, Gabriela, Mullan, Rebecca J., Hazem, Ahmad, Sundaresh, Vishnu, Elamin, Mohammed B., Phung, Olivia J., Wang, Amy +6 more·2013·The Journal of Clinical Endocrinology & Metabolism

Abstract

Context: Polycystic ovary syndrome (PCOS) is a prevalent disorder that affects women of childbearing age and may be related to obesity and insulin resistance. Objective: The purpose of this systematic review was to appraise the evidence of the impact of lifestyle modification (LSM) interventions on outcomes of women with PCOS. Data Sources: Sources included Ovid Medline, OVID Embase, OVID Cochrane Library, Web of Science, Scopus, PsycINFO, and CINAHL (up to January 2011). Study Selection: We included randomized controlled trials that enrolled woman of any age with PCOS who received LSM and compared them against women who received no intervention, minimal intervention, or metformin. Data Extraction: Two authors performed the data extraction independently. Data Synthesis: We included 9 trials enrolling 583 women with a high loss to follow-up rate, lack of blinding, and short follow-up. Compared with minimal intervention, LSM significantly reduced fasting blood glucose (weighted mean difference, −2.3 mg/dL; 95% confidence interval, −4.5 to −0.1, I2 = 72%, P = .04) and fasting blood insulin (weighted mean difference, −2.1 μU/mL, 95% confidence interval, −3.3 to −1.0, I2 = 0%, P < .001). Changes in body mass index were associated with changes in fasting blood glucose (P < .001). Metformin was not significantly better than LSM in improving blood glucose or insulin levels. We found no significant effect of LSM on pregnancy rate, and the effect on hirsutism was unclear. Conclusions: The available evidence suggests that LSM reduces fasting blood glucose and insulin levels in women with PCOS. Metformin has similar effects. Translation of these short-term effects to patient-important outcomes, beyond diabetes prevention, remains uncertain.

Integrity signals

Registry

Crossref · 10.1210/jc.2013-2385

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Domecq, J. P., Prutsky, G., Mullan, R. J., Hazem, A., Sundaresh, V., Elamin, M. B., Phung, O. J., Wang, A., Hoeger, K., Pasquali, R., Erwin, P., Bodde, A., Montori, V. M., & Murad, M. H.
Affiliations
  • Henry Ford Hospital (US)
  • Wayne State University (US)
  • University of Minnesota (US)
  • University of North Dakota (US)
  • Louisiana State University Health Sciences Center Shreveport (US)
  • Texas Tech University (US)
  • Western University of Health Sciences (US)
  • Mayo Clinic (US)
  • University of Rochester Medicine (US)
  • IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
  • Knowledge and Evaluation Research Unit (J.P.D., G.P., R.J.M., A.W., P.E., A.B., V.M.M., M.H.M.), Rochester, Minnesota 55905
Corresponding author
Murad, M. Hassan
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2013-12-01
Volume
98
Issue
12
Pages
4655-4663
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2153353583
Cited by
184
References
59
Citations by year
2026: 4 · 2025: 13 · 2024: 9 · 2023: 13 · 2022: 12 · 2021: 14 · 2020: 19 · 2019: 22 · 2018: 13 · 2017: 18 · 2016: 11 · 2015: 23 · 2014: 12 · 2013: 1
FWCI
2.53
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
Keywords
polycystic ovary syndrome, lifestyle modification, metformin, fasting blood glucose, insulin levels, body mass index, obesity, insulin resistance, hirsutism, pregnancy rate, diabetes prevention
MeSH terms
Combined Modality Therapy, Diet, Reducing, Female, Humans, Hyperglycemia, Hyperinsulinism, Life Style, Patient Compliance, Polycystic Ovary Syndrome, Pregnancy, Exercise, Randomized Controlled Trials as Topic, Pregnancy Rate, Evidence-Based Medicine, Overweight, Lost to Follow-Up

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review